Cargando…

The Effects of Use of Long-Term Second-Generation Antipsychotics on Liver and Kidney Function: A Prospective Study

(1) Background: The second-generation antipsychotics (SGAPs) induce metabolic and inflammatory side effects, but documentation of their effects on the liver and kidneys is scarce. Aim: To study the three-year fluctuation of selected markers of renal and hepatic function in forensic psychiatric patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papatriantafyllou, Evangelia, Efthymiou, Dimitris, Markopoulou, Maria, Sakellariou, Efthymia-Maria, Vassilopoulou, Emilia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332711/ https://www.ncbi.nlm.nih.gov/pubmed/35892742 http://dx.doi.org/10.3390/diseases10030048

Ejemplares similares

Long Term Metabolic and Inflammatory Effects of Second-Generation Antipsychotics: A Study in Mentally Disordered Offenders
por: Vassilopoulou, Emilia, et al.
Publicado: (2021)

Sleep Deprivation: Effects on Weight Loss and Weight Loss Maintenance
por: Papatriantafyllou, Evangelia, et al.
Publicado: (2022)

Gait Alterations in the Prediction of Metabolic Syndrome in Patients With Schizophrenia: A Pilot Study With PODOSmart ® Insoles
por: Efthymiou, Dimitris, et al.
Publicado: (2022)

Food Allergy Management Competence in Greek Schools
por: Feketea, Gavriela, et al.
Publicado: (2023)

Halting the Metabolic Complications of Antipsychotic Medication in Patients with a First Episode of Psychosis: How Far Can We Go with the Mediterranean Diet? A Pilot Study
por: Ntalkitsi, Savina, et al.
Publicado: (2022)

The benefits of the Mediterranean diet in first episode psychosis patients taking antipsychotics
por: Vassilopoulou, Emilia, et al.
Publicado: (2022)

Perceived ideal body weight exacerbates bulimia and dieting in Bodybuilding Athletes
por: Efthymiou, Dimitris, et al.
Publicado: (2021)

Long-Term Evolution of Metabolic Status in Patients with Schizophrenia Stably Maintained on Second-Generation Antipsychotics
por: Jeong, Seong Hoon, et al.
Publicado: (2018)

The Effect of Long-Term Second-Generation Antipsychotics Use on the Metabolic Syndrome Parameters in Jordanian Population
por: Abo Alrob, Osama, et al.
Publicado: (2019)

Second-Generation Antipsychotics and Extrapyramidal Adverse Effects
por: Divac, Nevena, et al.
Publicado: (2014)

Alliance with the School Personnel Is Crucial for the Management of Food Allergy and Anaphylaxis in School Children
por: Efthymiou, Dimitris, et al.
Publicado: (2021)

Gait Analysis, Metabolic Parameters and Adherence to the Mediterranean Diet in Patients with Type 2 Diabetes Mellitus Compared with Healthy Controls: A Pilot Study
por: Efthymiou, Dimitris, et al.
Publicado: (2023)

Teetering on the Edge: Second-Degree Atrioventricular Block Following Long-Acting Second-Generation Antipsychotic
por: Harrisingh, Kamahl, et al.
Publicado: (2023)

Arterial Stiffness in Patients Taking Second-generation Antipsychotics
por: Fındıklı, Ebru, et al.
Publicado: (2016)

Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia
por: Caruso, Giuseppe, et al.
Publicado: (2020)

Second-generation antipsychotic use during pregnancy and risk of congenital malformations
por: Ellfolk, Maria, et al.
Publicado: (2021)

First-generation vs second-generation antipsychotic drugs: The ongoing saga
por: Gupta, Sumeet
Publicado: (2010)

Second Generation Long-Acting Injectable Antipsychotics in Africa: About a Case
por: Galvañ, J., et al.
Publicado: (2023)

Second-generation antipsychotics and the risk of chronic kidney disease: a population-based case-control study
por: Højlund, Mikkel, et al.
Publicado: (2020)

Evaluation of oral antipsychotic supplementation of select second-generation long-acting injectable antipsychotics in an acute-care psychiatric setting
por: Alastanos, Jennifer N., et al.
Publicado: (2019)

Relapse Prevention in Schizophrenia: A Systematic Review and Meta-Analysis of Second-Generation Antipsychotics versus First-Generation Antipsychotics
por: Kishimoto, Taishiro, et al.
Publicado: (2011)

Efficacy and Tolerability of Second-Generation Antipsychotics in Children and Adolescents With Schizophrenia
por: Kumra, Sanjiv, et al.
Publicado: (2008)

Inhibition of mouse brown adipocyte differentiation by second-generation antipsychotics
por: Oh, Jee-Eun, et al.
Publicado: (2012)

Adherence and Continuation of Treatment with First- and Second-generation Antipsychotics in Schizophrenia
por: Warikoo, Nisha, et al.
Publicado: (2014)

Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update
por: Wang, Sheng-Min, et al.
Publicado: (2016)

Overcoming barriers to monitoring patients taking second-generation antipsychotics
por: Peña, Anita, et al.
Publicado: (2018)

Updating the Comparative Evidence on Second‐Generation Antipsychotic Use With Schizophrenia
por: McDonagh, Marian S., et al.
Publicado: (2020)

Combination treatment with second generation antipsychotics other than clozapine
por: Schmidt-Kraepelin, C.
Publicado: (2021)

Risk of Breast Cancer in Association with the Use of Second-generation Antipsychotics
por: Joo, Sung Woo, et al.
Publicado: (2022)

Factors Influencing the Use of Second-Generation Antipsychotics in Children with Psychosis
por: Ramachandran, Sujith, et al.
Publicado: (2016)

Comparison of hospitalizations in patients on first generation versus second generation long acting injectable (LAI) antipsychotics
por: Rasool, Seemab, et al.
Publicado: (2021)

Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
por: Montemagni, Cristiana, et al.
Publicado: (2016)

Adding Suicide Prevention to the Triple Advantages of Injectable Long-Acting Second-Generation Antipsychotics
por: Pompili, Maurizio
Publicado: (2020)

Student Disaffection: The Contribution of Greek In-service Kindergarten Teachers in Engaging Each Preschooler in Learning
por: Sakellariou, Maria, et al.
Publicado: (2020)

Effectiveness of second generation antipsychotics: A systematic review of randomized trials
por: Johnsen, Erik, et al.
Publicado: (2008)

Blood lactate levels in patients receiving first- or second- generation antipsychotics
por: Glavina, Trpimir, et al.
Publicado: (2011)

Second-Generation Antipsychotic Discontinuation in First Episode Psychosis: An Updated Review
por: Miller, Brian J., et al.
Publicado: (2011)

Dysphagia with second-generation antipsychotics: A case report and review of the literature
por: Crouse, Ericka L., et al.
Publicado: (2018)

Controversies in bipolar disorder; role of second-generation antipsychotic for maintenance therapy
por: Jauhar, Sameer, et al.
Publicado: (2019)

Intentional Recreational Abuse of Quetiapine Compared to Other Second-generation Antipsychotics
por: Klein, Lauren, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4imfp45ufhuqp5kh8b9h1bu3pj